Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjersti Flatmark

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|February 19, 2013
Molecular modelling and simulations in cancer researchRan Friedman, Kjetil Boye, Kjersti Flatmark
The American Journal of Pathology|September 11, 2010
MicroRNAs as biomarkers in colorectal cancerKristina Schee, Øystein Fodstad, Kjersti Flatmark
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
microRNAs as cancer biomarkersKjersti Flatmark, Eirik Høye, Bastian Fromm
The British Journal of Radiology|June 3, 2026
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trialAnne Hansen Ree, Sebastian Meltzer, Kjersti Flatmark, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 30, 2024
Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal MesotheliomaBen Davidson, Arild Holth, Charlotte Hummel, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 19, 2011
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patientsKristina Schee, Kjersti Flatmark, Ruth Holm, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative reviewChristin Lund-Andersen, Annette Torgunrud, Karianne Giller Fleten, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation statusSigurd Folkvord, Anne Hansen Ree, Torbjørn Furre, et al.
International Journal of Molecular Sciences|December 16, 2014
Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networksAnne Hansen Ree, Sebastian Meltzer, Kjersti Flatmark, et al.
Radiation Oncology (London, England)|April 9, 2011
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapyAse Bratland, Svein Dueland, Donal Hollywood, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|February 19, 2013
Molecular modelling and simulations in cancer researchRan Friedman, Kjetil Boye, Kjersti Flatmark
The American Journal of Pathology|September 11, 2010
MicroRNAs as biomarkers in colorectal cancerKristina Schee, Øystein Fodstad, Kjersti Flatmark
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 20, 2016
microRNAs as cancer biomarkersKjersti Flatmark, Eirik Høye, Bastian Fromm
The British Journal of Radiology|June 3, 2026
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trialAnne Hansen Ree, Sebastian Meltzer, Kjersti Flatmark, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 30, 2024
Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal MesotheliomaBen Davidson, Arild Holth, Charlotte Hummel, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 19, 2011
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patientsKristina Schee, Kjersti Flatmark, Ruth Holm, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative reviewChristin Lund-Andersen, Annette Torgunrud, Karianne Giller Fleten, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation statusSigurd Folkvord, Anne Hansen Ree, Torbjørn Furre, et al.
International Journal of Molecular Sciences|December 16, 2014
Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networksAnne Hansen Ree, Sebastian Meltzer, Kjersti Flatmark, et al.
Radiation Oncology (London, England)|April 9, 2011
Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapyAse Bratland, Svein Dueland, Donal Hollywood, et al.
Pageof 14